Delta Becoming Globally Dominant: WHO

Geneva: The Delta variant, first identified in India, is becoming the globally dominant variant of the disease, the WHO’s chief scientist Soumya Swaminathan said on Friday.

According to the Covid-19 Weekly Epidemiological Update issued by the WHO on June 15, the Delta variant is now being reported in about 80 countries around the world. Another 12 countries and areas are “reporting the detection of B.1.617 without further specification of lineage at this time.”

“The whole situation is so dynamic because of the variants that are now circulating and…the Delta variant is well on its way to becoming the dominant variant globally because of its significantly increased transmissibility,” Swaminathan said responding to a question at a press briefing.

Her remarks came hours after Public Health England said that the number of Delta variant cases has jumped by 33,630 in a week to hit a total of 75,953 in the UK, with the highly transmissible variant now making up 99% of all cases in the country. The rise was a 79% increase on the previous week’s tally. On Friday, vaccinations were opened up to all people over 18 in England.

In Washington, CDC director Rochelle Walensky said she expects the Delta variant will become the dominant coronavirus strain in the US. “As worrisome as this delta strain is with regard to its hyper transmissibility, our vaccines work,” Walensky told ABC News.

The Kremlin in Russia blamed a surge in cases on reluctance to have vaccinations and “nihilism” after a record 9,056 new infections in Moscow, mostly with the Delta variant, fanned fears of a third wave. “According to the latest data, 89.3% of Muscovites (recently) diagnosed with Covid-19 have the mutated, so-called Delta or Indian variant,” the news agency TASS quoted Moscow Mayor Sergei Sobyanin as saying.

In Germany, top public health official predicted Delta would rapidly become the dominant variant there despite rising vaccination rates. Agencies

  • Related Posts

    Cancer drug makers seek 50% price hike as platinum surge hits production viability

    Mumbai | Delhi: Manufacturing of cancer medicines such as carboplatin, oxaliplatin and cisplatin has become unviable due to a surge in the price of platinum, a critical component in these…

    CDRI’s new research hub in Lucknow to facilitate innovation in drug discovery & development

    Lucknow:  Marking 70 years of its inception, the Central Drug Research Institute (CDRI) in Lucknow launched a new and advanced research facility called Common Research and Technology Development Hub (CRTDH).…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Cancer drug makers seek 50% price hike as platinum surge hits production viability

    Cancer drug makers seek 50% price hike as platinum surge hits production viability

    CDRI’s new research hub in Lucknow to facilitate innovation in drug discovery & development

    CDRI’s new research hub in Lucknow to facilitate innovation in drug discovery & development

    Delhi Police busts racket diverting govt-supplied medicines for private sale; 3 held

    Delhi Police busts racket diverting govt-supplied medicines for private sale; 3 held

    Niti Aayog & DPIIT Decriminalize Med Device Penalties for Ease of Business

    Niti Aayog & DPIIT Decriminalize Med Device Penalties for Ease of Business

    Laser rescued an Imperiled Food Pipe in Sir Ganga Ram Hospital

    Laser rescued an Imperiled Food Pipe in Sir Ganga Ram Hospital

    Centre gives custom cushion to supply strained Pharma, MedTech manufacturers

    Centre gives custom cushion to supply strained Pharma, MedTech manufacturers